New cancer chemotherapeutic agents.
D000447:Aldehydes / Q000627:therapeutic use; D000577:Amides / Q000627:therapeutic use; D000588:Amines / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001215:Asparaginase / Q000627:therapeutic use; D001374:Azacitidine / Q000627:therapeutic use; D001375:Azaguanine / Q000627:therapeutic use; D001761:Bleomycin / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D002712:Chlorides / Q000627:therapeutic use; D003500:Cyclization; D003510:Cyclohexanes / Q000627:therapeutic use; D003561:Cytarabine / Q000627:therapeutic use; D003562:Cytidine / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D006027:Glycosides / Q000627:therapeutic use; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007093:Imidazoles / Q000627:therapeutic use; D007945:Leukemia, Lymphoid / Q000188:drug therapy; D007951:Leukemia, Myeloid / Q000188:drug therapy; D051379:Mice; D009607:Nitrosourea Compounds / Q000627:therapeutic use; D010848:Picolinic Acids / Q000627:therapeutic use; D010984:Platinum / Q000627:therapeutic use; D011034:Podophyllotoxin / Q000627:therapeutic use; D013311:Streptozocin / Q000627:therapeutic use; D013882:Thiosemicarbazones / Q000627:therapeutic use; D014226:Triazenes / Q000627:therapeutic use
D000447:Aldehydes; D000577:Amides; D000588:Amines; D000970:Antineoplastic Agents; D002712:Chlorides; D003510:Cyclohexanes; D006027:Glycosides; D007093:Imidazoles; D009607:Nitrosourea Compounds; D010848:Picolinic Acids; D013882:Thiosemicarbazones; D014226:Triazenes; D003561:Cytarabine; D001761:Bleomycin; D010984:Platinum; D003562:Cytidine; D013311:Streptozocin; D004317:Doxorubicin; D001215:Asparaginase; D011034:Podophyllotoxin; D001374:Azacitidine; D001375:Azaguanine; D002330:Carmustine; D006918:Hydroxyurea